Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for AMLOGENYX with the United States Patent and Trademark Office. The USPTO has given the AMLOGENYX trademark a serial number of 98745228. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, March 27, 2025. This trademark is owned by Amlogenyx Inc.. The AMLOGENYX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing medical services, namely, gene therapy medical services in the field of neurological and genetic diseases and disorders; medical consultations in the field of neurological and genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of neurological and genetic diseases and disorders, and collecting data and information on neurological and genetic diseases and disorders for screening, diagnosis and treatment purposes; medical information services in the nature of providing a database in the field of neurological and genetic diseases and disorder information based on collected patient data and information all for treatment and diagnostic purposes
